Indeed, when analyzing signaling changes in tumor tissues, we demonstrate that LB-100 administration activated AMPK (AMPKα1/ACC phosphorylations) in HCT-116 tumors (Figure 6D), which was followed by mTORC1 (p-p70S6K1) inhibition (Figure 6F). The gene discussed is RPS6KB1; the disease is neoplasm.